Risk stratification for adult patients with pulmonary arterial hypertension associated with congenital heart disease

For patients with pulmonary arterial hypertension (PAH), current guidelines recommend a 3- and 4-strata risk stratification model at baseline and follow-up, respectively. Risk stratification models in PAH are mainly derived from idiopathic PAH cohorts and are not automatically applicable to all patients with PAH associated with congenital heart disease (CHD), especially in those with Eisenmenger syndrome, given the differences in pathophysiology and clinical phenotype. Additional features such as shunt location, complexity of CHD, degree of cyanosis, iron deficiency, syndromic co-morbidity and biomarkers, other than brain natriuretic peptide may play an important role in the prognostication of these patients. This scientific statement aims to discuss in detail individual prognosticators and propose a comprehensive model of risk stratification for patients with PAH-CHD, mainly those with Eisenmenger syndrome.

Authors

Institutions

Publication Details

Journal
European Journal of Heart Failure
Published
2026-03-04
DOI
https://doi.org/10.1093/ejhf/xuag059
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk stratification for adult patients with pulmonary arterial hypertension associated with congenital heart disease

Teiji Akagi, Alexandra Arvanitaki, Jamil Aboulhosn, Margarita Brida et al.
European Journal of Heart Failure
Pulmonary Hypertension Research and Treatments
article

Risk stratification for adult patients with pulmonary arterial hypertension associated with congenital heart disease

Teiji Akagi, Alexandra Arvanitaki, Jamil Aboulhosn, Margarita Brida, Barbro Kjellström, G Diller, Ewa Mroczek, P. Martín Escribano, Konstantinos Dimopoulos, Roberto Badagliacca, Stephan Rosenkranz, Michele D’Alto, George Giannakoulas, Marc Humbert, Michael A Gatzoulis, Jeroen Bax
article en

Abstract

For patients with pulmonary arterial hypertension (PAH), current guidelines recommend a 3- and 4-strata risk stratification model at baseline and follow-up, respectively. Risk stratification models in PAH are mainly derived from idiopathic PAH cohorts and are not automatically applicable to all patients with PAH associated with congenital heart disease (CHD), especially in those with Eisenmenger syndrome, given the differences in pathophysiology and clinical phenotype. Additional features such as shunt location, complexity of CHD, degree of cyanosis, iron deficiency, syndromic co-morbidity and biomarkers, other than brain natriuretic peptide may play an important role in the prognostication of these patients. This scientific statement aims to discuss in detail individual prognosticators and propose a comprehensive model of risk stratification for patients with PAH-CHD, mainly those with Eisenmenger syndrome.

European Journal of Heart Failure
Karolinska University Hospital (SE), University of Rijeka (HR), Université Paris-Saclay (FR), Leiden University Medical Center (NL), AHEPA University Hospital (GR), Ronald Reagan UCLA Medical Center (US), Harefield Hospital (GB), Wroclaw Medical University (PL), Royal Brompton Hospital (GB), Okayama University Hospital (JP), Hospital Universitario 12 De Octubre (ES), University Hospital Münster (DE), National Heart Hospital (BG), Ospedale Monaldi (IT), University Hospital Cologne (DE), Bicêtre Hospital (FR), Sapienza University of Rome (IT)
Good health and well-being
Openalex Percentile: Top 28%
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.